Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not …

…, RB Barkardottir, K Backenhorn… - Journal of medical …, 2006 - jmg.bmj.com
Background: BARD1 was originally identified as a BRCA1-interacting protein but has also
been described in tumour-suppressive functions independent of BRCA1. Several studies …

AURKA F31I Polymorphism and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Consortium of Investigators of Modifiers of BRCA1/2 Study

…, HFA Vasen, A Borg, K Backenhorn… - … Biomarkers & Prevention, 2007 - AACR
The AURKA oncogene is associated with abnormal chromosome segregation and
aneuploidy and predisposition to cancer. Amplification of AURKA has been detected at …